Paras Health Sgr successfully removes rare malignant tumour

RK News
Comments 0
22 Feb 2026

Srinagar, Feb 21: Paras Health Srinagar successfully treated a patient diagnosed with an exceptionally rare malignant tumor — chondrosarcoma, a type of bone cancer affecting the upper part of the breastbone (manubrium sterni). According to a statement issued here, the patient presented with a localized swelling over the chest wall, and detailed imaging confirmed a rare bone tumor arising from the upper breastbone. Given the aggressive nature of the disease, the medical team performed a complete surgical removal of the tumor, which remains the most definitive treatment for such cases. The highly complex surgery was performed by the Surgical Oncology team led by Dr. Shah Naveed, in collaboration with the Thoracic Surgery team comprising Dr Syed Asrar Qadri and Dr Mudasir, with perioperative support from the Anesthesia team and the Surgical Intensive Care Unit (SICU). Chondrosarcoma of the manubrium sterni is reported in only a very small number of cases worldwide. Primary tumors of the sternum account for less than 1% of all primary bone neoplasms, making this an extremely uncommon presentation. Tumors in this location are particularly challenging due to their proximity to critical chest structures. Successful management requires meticulous planning to achieve complete tumor clearance while preserving chest wall stability and normal respiratory function. Dr. Murtuza Habib, Facility Director, Paras Health Srinagar, said, “Cases like these test not just surgical skill but the strength of an institution’s clinical systems. Managing a rare chest wall cancer requires precise planning, multidisciplinary coordination, and robust critical care support. The successful outcome reflects our teams' preparedness and our continued effort to build advanced treatment capabilities within the region.” During the surgery, doctors removed the affected portion of the breastbone along with the surrounding involved tissue in one piece to ensure complete tumor clearance. They then reconstructed the chest wall to maintain its strength and allow normal breathing. After the procedure, the patient remained stable throughout her hospital stay. Chest tubes were removed once the drainage reduced. Follow-up scans showed satisfactory recovery, and the surgical wound healed well. The patient is clinically stable and is planned for discharge. Doctors emphasised that early diagnosis and a multidisciplinary team-based approach remain critical in managing rare bone tumors. This case highlights the importance of timely evaluation of persistent chest wall swellings and reflects the growing capability to manage complex oncological and thoracic conditions with comprehensive critical care support.